CNS5:Diffuse midline glioma, H3 K27-altered - Revision history

Richard.Glen at 00:50, 26 February 2026

2026-02-26T00:50:27Z

← Older revision		Revision as of 19:50, 25 February 2026
Line 567:		Line 567:


	(use the "Cite" icon at the top of the page) <span style="color:#0070C0">(''Instructions: Add each reference into the text above by clicking where you want to insert the reference, selecting the “Cite” icon at the top of the wiki page, and using the “Automatic” tab option to search by PMID to select the reference to insert. If a PMID is not available, such as for a book, please use the “Cite” icon, select “Manual” and then “Basic Form”, and include the entire reference. To insert the same reference again later in the page, select the “Cite” icon and “Re-use” to find the reference; DO NOT insert the same reference twice using the “Automatic” tab as it will be treated as two separate references. The reference list in this section will be automatically generated and sorted''</span><span style="color:#0070C0">''.''</span><span style="color:#0070C0">)</span><references />		(use the "Cite" icon at the top of the page) <span style="color:#0070C0">(''Instructions: Add each reference into the text above by clicking where you want to insert the reference, selecting the “Cite” icon at the top of the wiki page, and using the “Automatic” tab option to search by PMID to select the reference to insert. If a PMID is not available, such as for a book, please use the “Cite” icon, select “Manual” and then “Basic Form”, and include the entire reference. To insert the same reference again later in the page, select the “Cite” icon and “Re-use” to find the reference; DO NOT insert the same reference twice using the “Automatic” tab as it will be treated as two separate references. The reference list in this section will be automatically generated and sorted''</span><span style="color:#0070C0">''.''</span><span style="color:#0070C0">)</span>
			<references />

	==Notes==		==Notes==

Richard.Glen at 00:45, 26 February 2026

2026-02-26T00:45:48Z

Show changes

Bailey.Glen at 18:29, 13 January 2026

2026-01-13T18:29:27Z

← Older revision		Revision as of 13:29, 13 January 2026
Line 38:		Line 38:
	\|+		\|+
	\|Acceptable		\|Acceptable
	\|~~Age-related clonal haematopoiesis (ARCH)~~		\|Diffuse Intrinsic Pontine Glioma
	\|-		\|-
	\|Not Recommended		\|Not Recommended

Bailey.Glen at 18:23, 13 January 2026

2026-01-13T18:23:45Z

← Older revision		Revision as of 13:23, 13 January 2026
Line 34:		Line 34:

	==Related Terminology==		==Related Terminology==

			{\| class="wikitable"
			\|+
			\|Acceptable
			\|Age-related clonal haematopoiesis (ARCH)
			\|-
			\|Not Recommended
			\|N/A
			\|}

	==Gene Rearrangements==		==Gene Rearrangements==

Bailey.Glen: template fix

2026-01-13T18:22:58Z

template fix

@@ Line 11: / Line 11: @@
 Linda Cooley, MD, MBA, Children's Mercy Hospital
 ==WHO Classification of Disease==
@@ Line 35: / Line 33: @@
 |}
-==Definition / Description of Disease==
+==Related Terminology==
 ==Gene Rearrangements==

Bailey.Glen at 21:54, 25 May 2025

2025-05-25T21:54:57Z

← Older revision		Revision as of 16:54, 25 May 2025
Line 156:		Line 156:
	{\| class="wikitable sortable"		{\| class="wikitable sortable"
	\|-		\|-
	!Chr #!!~~'''~~Gain, Loss, Amp, LOH~~'''~~!!~~'''~~Minimal Region Cytoband and/or Genomic Coordinates [Genome Build; Size]~~'''~~!!~~'''~~Relevant Gene(s)~~'''~~		!Chr #!!Gain, Loss, Amp, LOH!!Minimal Region Cytoband and/or Genomic Coordinates [Genome Build; Size]!!Relevant Gene(s)
	!~~'''~~Diagnostic, Prognostic, and Therapeutic Significance - D, P, T~~'''~~		!Diagnostic, Prognostic, and Therapeutic Significance - D, P, T
	!~~'''~~Established Clinical Significance Per Guidelines - Yes or No (Source)~~'''~~		!Established Clinical Significance Per Guidelines - Yes or No (Source)
	!~~'''~~Clinical Relevance Details/Other Notes~~'''~~		!Clinical Relevance Details/Other Notes
	\|-		\|-
	\|<span class="blue-text">EXAMPLE:</span>		\|<span class="blue-text">EXAMPLE:</span>
Line 242:		Line 242:
	!Chromosomal Pattern		!Chromosomal Pattern
	!Molecular Pathogenesis		!Molecular Pathogenesis
	!~~'''~~Prevalence -~~'''~~		!Prevalence -
	~~'''~~Common >20%, Recurrent 5-20% or Rare <5% (Disease)~~'''~~		Common >20%, Recurrent 5-20% or Rare <5% (Disease)
	!~~'''~~Diagnostic, Prognostic, and Therapeutic Significance - D, P, T~~'''~~		!Diagnostic, Prognostic, and Therapeutic Significance - D, P, T
	!~~'''~~Established Clinical Significance Per Guidelines - Yes or No (Source)~~'''~~		!Established Clinical Significance Per Guidelines - Yes or No (Source)
	!~~'''~~Clinical Relevance Details/Other Notes~~'''~~		!Clinical Relevance Details/Other Notes
	\|-		\|-
	\|<span class="blue-text">EXAMPLE:</span>		\|<span class="blue-text">EXAMPLE:</span>
Line 278:		Line 278:
	{\| class="wikitable sortable"		{\| class="wikitable sortable"
	\|-		\|-
	!Gene!!~~'''~~Genetic Alteration~~'''~~!!~~'''~~Tumor Suppressor Gene, Oncogene, Other~~'''~~!!~~'''~~Prevalence -~~'''~~		!Gene!!Genetic Alteration!!Tumor Suppressor Gene, Oncogene, Other!!Prevalence -
	~~'''~~Common >20%, Recurrent 5-20% or Rare <5% (Disease)~~'''~~		Common >20%, Recurrent 5-20% or Rare <5% (Disease)
	!~~'''~~Diagnostic, Prognostic, and Therapeutic Significance - D, P, T ~~'''~~		!Diagnostic, Prognostic, and Therapeutic Significance - D, P, T
	!~~'''~~Established Clinical Significance Per Guidelines - Yes or No (Source)~~'''~~		!Established Clinical Significance Per Guidelines - Yes or No (Source)
	!~~'''~~Clinical Relevance Details/Other Notes~~'''~~		!Clinical Relevance Details/Other Notes
	\|-		\|-
	\|<span class="blue-text">EXAMPLE:</span>''EGFR''		\|<span class="blue-text">EXAMPLE:</span>''EGFR''

Bailey.Glen at 19:39, 25 May 2025

2025-05-25T19:39:09Z

← Older revision		Revision as of 14:39, 25 May 2025
Line 1:		Line 1:
	{{DISPLAYTITLE:Diffuse midline glioma, H3 K27-altered}}		{{DISPLAYTITLE:Diffuse midline glioma, H3 K27-altered}}

	[[CNS5:Table_of_Contents\|Central Nervous System Tumours(WHO Classification, 5th ed.)]]		[[CNS5:Table_of_Contents\|Central Nervous System Tumours (WHO Classification, 5th ed.)]]

	{{Under Construction}}		{{Under Construction}}

Bailey.Glen at 14:41, 27 March 2025

2025-03-27T14:41:16Z

@@ Line 1: / Line 1: @@
 {{DISPLAYTITLE:Diffuse midline glioma, H3 K27-altered}}
 [[CNS5:Table_of_Contents|Central Nervous System Tumours(WHO Classification, 5th ed.)]]
@@ Line 10: / Line 11: @@
 Linda Cooley, MD, MBA, Children's Mercy Hospital
@@ Line 151: / Line 151: @@
+|
 |}
 ==Individual Region Genomic Gain/Loss/LOH==
@@ Line 258: / Line 233: @@
 |-
 | ||gains||1q, 2 (1)
 |}
@@ Line 338: / Line 271: @@
+|
 |}
 ==Gene Mutations (SNV/INDEL)==
@@ Line 466: / Line 374: @@
 Prior Author(s):
 <nowiki>*</nowiki>''Citation of this Page'': “Diffuse midline glioma, H3 K27-altered”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/CNS5:Diffuse midline glioma, H3 K27-altered</nowiki>.
-[[Category:CNS5]][[Category:DISEASE]][[Category:Diseases D]]
+[[Category:CNS5]]

Bailey.Glen at 17:52, 24 March 2025

2025-03-24T17:52:00Z

Show changes

Jennelleh: Jennelleh moved page Diffuse Midline Glioma, H3 K27-Altered to CNS5:Diffuse midline glioma, H3 K27-altered without leaving a redirect: Move to CNS5

2024-02-25T18:51:10Z

Jennelleh moved page Diffuse Midline Glioma, H3 K27-Altered to CNS5:Diffuse midline glioma, H3 K27-altered without leaving a redirect: Move to CNS5

← Older revision		Revision as of 13:51, 25 February 2024
(No difference)